A Closer Look at TG Therapeutics's Options Market Dynamics
Portfolio Pulse from Benzinga Insights
Financial giants have shown a bullish stance on TG Therapeutics (NASDAQ:TGTX) with 62% of traders being bullish. The options market reveals significant trades, with a predicted price range of $15.0 to $20.0. The stock is currently trading at $22.04, up by 5.23%, and analysts have mixed ratings with price targets ranging from $20 to $49.
August 16, 2024 | 5:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Financial giants are showing a bullish stance on TG Therapeutics with significant options trades. The stock is currently trading at $22.04, up by 5.23%. Analysts have mixed ratings with price targets ranging from $20 to $49.
The bullish sentiment in the options market, combined with the stock's recent price increase and mixed analyst ratings, suggests a positive short-term outlook for TGTX. The significant options trades indicate investor confidence in the stock's upward potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100